Mosaic’s becoming

2023-09-11T16:06:43+01:0012 September 2023|

The Sanger Institute is committed to innovative science at scale, but we need partners and investors to transfer this science into the clinic. Mariya Chhatriwala, Business Development Manager, gives us her insights on how the Sanger Institute’s fifth spin-out company came to be.

Behind the Heart Cell Atlas

2023-07-14T22:55:48+01:0012 July 2023|

Histologists, cardiologists, immunologists, cell biologists, software developers, bioinformaticians and specialist technicians have worked together to see individual cells in unprecedented detail. Using spatial genomics, they located each cell to its precise location in the heart.

New postdoc award scheme winners

2023-02-21T12:16:24+00:0021 February 2023|

Meet the first two winners of our new internal funding scheme to accelerate postdocs along their career trajectory

To influenza and beyond

2023-01-12T12:11:55+00:0010 January 2023|

The Sanger Institute’s new Respiratory Virus and Microbiome Initiative will lead the way in developing the genomic tools and methodology to study and track a range of viruses and understand how they interact with the respiratory microbiome and human hosts.

Understand, predict, engineer

2022-11-03T12:56:59+00:003 November 2022|

Ben Lehner joins the Sanger Institute as a new Senior Group Leader. He seeks to lay the foundations for programmable biology.

From genomes to medicines: an interview with Ian Dunham

2022-12-01T12:44:55+00:0019 October 2022|

Ian Dunham has been a pillar of Open Targets since its inception. Helena Cornu sat down with him to understand how his career led him from the Human Genome Project to Director of Open Targets, and what he envisions for the future of the consortium.‌